Title |
Successful radioimmunotherapy of established syngeneic rat colon carcinoma with 211At-mAb
|
---|---|
Published in |
EJNMMI Research, April 2013
|
DOI | 10.1186/2191-219x-3-23 |
Pubmed ID | |
Authors |
Sophie E Eriksson, Tom Bäck, Erika Elgström, Holger Jensen, Rune Nilsson, Sture Lindegren, Jan Tennvall |
Abstract |
Most carcinomas are prone to metastasize despite successful treatment of the primary tumor. One way to address this clinical challenge may be targeted therapy with α-emitting radionuclides such as astatine-211 (211At). Radioimmunotherapy utilizing α-particle emitting radionuclides is considered especially suitable for the treatment of small cell clusters and single cells, although lesions of different sizes may also be present in the patient. The aim of this study was primarily to evaluate the toxicity and secondarily in vivo efficacy of a 211At-labeled monoclonal antibody (mAb) directed against colon carcinoma with tumor diameters of approximately 10 mm. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 7% |
Unknown | 14 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 4 | 27% |
Researcher | 3 | 20% |
Professor > Associate Professor | 2 | 13% |
Student > Master | 2 | 13% |
Student > Bachelor | 1 | 7% |
Other | 2 | 13% |
Unknown | 1 | 7% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 4 | 27% |
Physics and Astronomy | 3 | 20% |
Agricultural and Biological Sciences | 2 | 13% |
Chemistry | 2 | 13% |
Business, Management and Accounting | 1 | 7% |
Other | 1 | 7% |
Unknown | 2 | 13% |